Ads
related to: Brainstorm Cell Therapeutics- Stem Cell FAQs
Discover questions about stem cell
therapy and the TruStem difference.
- TruStem Cell Reviews
Read reviews from our patients
and see why TruStem is top rated.
- Parkinson's Disease
Discover What Steps Are Involved In
Receiving Treatment Through TruStem
- Our Treatment Center
Learn about each doctor, clinician
and our state-of-the-art facility.
- Patient Testimonials
Discover patient reviews after
having TruStem Cell Therapy
- Stroke
Explore What Steps Are Involved In
Receiving Treatment Through TruStem
- Stem Cell FAQs
Search results
Zacks Small Cap Weighs in on Brainstorm Cell Therapeutics Inc.’s Q1 2024 Earnings (NASDAQ:BCLI)
ETF DAILY NEWS· 4 days agoBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Free Report) – Analysts at Zacks Small Cap issued their Q1 2024 earnings ...
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b...
FOX 8 Cleveland· 3 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell
BrainStorm Cell Therapeutics promotes Bob Dagher to Chief Medical Officer
Seeking Alpha· 3 days agoBrainStorm Cell Therapeutics (BCLI) announces the promotion of Bob Dagher to Executive Vice President and Chief Medical Officer. Read more here.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Update
ETF DAILY NEWS· 3 weeks agoBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant decline in short ...
FDA agrees to BrainStorm Cell Therapeutics' Phase 3b ALS trial design
Investing.com· 2 weeks agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a pioneer in adult stem cell therapies for...
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
KTLA-TV Los Angeles· 1 week agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI, "the Company"), a leading developer of cellular therapies for neurodegenerative ...
NurOwn shows promise in ALS biomarker impact By Investing.com
Investing.com· 1 week agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a developer of cellular therapies for...
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate...
Morningstar· 3 weeks agoConference call planned for early April 2024 to provide update on NurOwn program NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics ...
BrainStorm stock gains as FDA OKs ALS trial (NASDAQ:BCLI)
Seeking Alpha· 2 weeks agoBrainStorm Cell Therapeutics (BCLI) stock gains as FDA endorses a late-stage trial for NurOwn, a ...
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket -...
Benzinga· 2 weeks agoShares of Biophytis S.A. BPTS rose sharply in today’s pre-market trading after reporting FY23...
Ads
related to: Brainstorm Cell Therapeuticstrustemcell.com has been visited by 10K+ users in the past month
